Vasoactive intestinal peptide suppresses neuronal cell death induced by nerve growth factor deprivation in rat sympathetic ganglion cells in vitro

Neuropeptides. 1994 Feb;26(2):103-11. doi: 10.1016/0143-4179(94)90101-5.

Abstract

Neuropeptides were examined for their effects on the survival of cultured rat superior cervical ganglion cells after acute deprivation of nerve growth factor (NGF). Vasoactive intestinal peptide (VIP, 3 microM) delayed the neuronal death about 6 h alone. The phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (0.2 mM) greatly potentiated its effect, reducing EC50 from 2.5 microM to 8 nM. The neuronal death was completely suppressed under this condition. On the other hand, substance P (1-100 microM) or enkephalin (1-100 microM) alone did not modify the death, whereas the latter (100 microM) enhanced the survival-promoting effect of membrane depolarization with elevated K+. These results suggest strongly that neuropeptides regulate the NGF-independent survival of sympathetic neurons through a cAMP-dependent mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Animals
  • Calcium / metabolism
  • Cell Death / drug effects*
  • Cells, Cultured
  • Cyclic AMP / pharmacology
  • Enkephalins / pharmacology
  • Ganglia, Sympathetic / cytology*
  • Ganglia, Sympathetic / drug effects
  • Nerve Growth Factors / administration & dosage
  • Nerve Growth Factors / physiology*
  • Neurites / physiology
  • Neurons / drug effects
  • Neurons / physiology*
  • Neurons / ultrastructure
  • Potassium / pharmacology
  • Rats
  • Rats, Wistar
  • Vasoactive Intestinal Peptide / pharmacology*

Substances

  • Enkephalins
  • Nerve Growth Factors
  • Vasoactive Intestinal Peptide
  • Cyclic AMP
  • Potassium
  • Calcium
  • 1-Methyl-3-isobutylxanthine